United States Carbetocin (Duratocin) Market Report 2017

January 2018 | 105 pages | ID: UA3F7C2C736EN
QYResearch

Abstracts

In this report, the United States Carbetocin (Duratocin) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Carbetocin (Duratocin) in these regions, from 2012 to 2022 (forecast).

United States Carbetocin (Duratocin) market competition by top manufacturers/players, with Carbetocin (Duratocin) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Beacon Pharmaceuticals Limited
• Ferring Inc.
• Polypeptide Laboraries France
• Chemos GmbH & Co. KG
• Hangzhou Dayangchem Co. Ltd.
• Acinopeptide Co., Ltd.
• Bachem AG
• Clearsynth Canada INC.
• Leap Labchem Co., Ltd
• Chemieliva Pharmaceutical Co., Ltd.
• Acinopeptide Co., Ltd.
• BOC Sciences

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablets
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oxytocic
• Antihemorrhagic
• Uterotonic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Carbetocin (Duratocin) Market Report 2017

1 CARBETOCIN (DURATOCIN) OVERVIEW

1.1 Product Overview and Scope of Carbetocin (Duratocin)
1.2 Classification of Carbetocin (Duratocin) by Product Category
  1.2.1 United States Carbetocin (Duratocin) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Carbetocin (Duratocin) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Injection
1.3 United States Carbetocin (Duratocin) Market by Application/End Users
  1.3.1 United States Carbetocin (Duratocin) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oxytocic
  1.3.3 Antihemorrhagic
  1.3.4 Uterotonic
1.4 United States Carbetocin (Duratocin) Market by Region
  1.4.1 United States Carbetocin (Duratocin) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Carbetocin (Duratocin) Status and Prospect (2012-2022)
  1.4.3 Southwest Carbetocin (Duratocin) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Carbetocin (Duratocin) Status and Prospect (2012-2022)
  1.4.5 New England Carbetocin (Duratocin) Status and Prospect (2012-2022)
  1.4.6 The South Carbetocin (Duratocin) Status and Prospect (2012-2022)
  1.4.7 The Midwest Carbetocin (Duratocin) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Carbetocin (Duratocin) (2012-2022)
  1.5.1 United States Carbetocin (Duratocin) Sales and Growth Rate (2012-2022)
  1.5.2 United States Carbetocin (Duratocin) Revenue and Growth Rate (2012-2022)

2 UNITED STATES CARBETOCIN (DURATOCIN) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Carbetocin (Duratocin) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Carbetocin (Duratocin) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Carbetocin (Duratocin) Average Price by Players/Suppliers (2012-2017)
2.4 United States Carbetocin (Duratocin) Market Competitive Situation and Trends
  2.4.1 United States Carbetocin (Duratocin) Market Concentration Rate
  2.4.2 United States Carbetocin (Duratocin) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Carbetocin (Duratocin) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CARBETOCIN (DURATOCIN) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Carbetocin (Duratocin) Sales and Market Share by Region (2012-2017)
3.2 United States Carbetocin (Duratocin) Revenue and Market Share by Region (2012-2017)
3.3 United States Carbetocin (Duratocin) Price by Region (2012-2017)

4 UNITED STATES CARBETOCIN (DURATOCIN) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Carbetocin (Duratocin) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Carbetocin (Duratocin) Revenue and Market Share by Type (2012-2017)
4.3 United States Carbetocin (Duratocin) Price by Type (2012-2017)
4.4 United States Carbetocin (Duratocin) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CARBETOCIN (DURATOCIN) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Carbetocin (Duratocin) Sales and Market Share by Application (2012-2017)
5.2 United States Carbetocin (Duratocin) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CARBETOCIN (DURATOCIN) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Beacon Pharmaceuticals Limited
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Ferring Inc.
  6.2.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Polypeptide Laboraries France
  6.3.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Chemos GmbH & Co. KG
  6.4.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hangzhou Dayangchem Co. Ltd.
  6.5.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Acinopeptide Co., Ltd.
  6.6.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bachem AG
  6.7.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Clearsynth Canada INC.
  6.8.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Leap Labchem Co., Ltd
  6.9.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Chemieliva Pharmaceutical Co., Ltd.
  6.10.2 Carbetocin (Duratocin) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Acinopeptide Co., Ltd.
6.12 BOC Sciences

7 CARBETOCIN (DURATOCIN) MANUFACTURING COST ANALYSIS

7.1 Carbetocin (Duratocin) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Carbetocin (Duratocin)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Carbetocin (Duratocin) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Carbetocin (Duratocin) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CARBETOCIN (DURATOCIN) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Carbetocin (Duratocin) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Carbetocin (Duratocin) Sales Volume Forecast by Type (2017-2022)
11.3 United States Carbetocin (Duratocin) Sales Volume Forecast by Application (2017-2022)
11.4 United States Carbetocin (Duratocin) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Carbetocin (Duratocin)
Figure United States Carbetocin (Duratocin) Market Size (K Units) by Type (2012-2022)
Figure United States Carbetocin (Duratocin) Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Injection Product Picture
Figure United States Carbetocin (Duratocin) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Carbetocin (Duratocin) by Application in 2016
Figure Oxytocic Examples
Table Key Downstream Customer in Oxytocic
Figure Antihemorrhagic Examples
Table Key Downstream Customer in Antihemorrhagic
Figure Uterotonic Examples
Table Key Downstream Customer in Uterotonic
Figure United States Carbetocin (Duratocin) Market Size (Million USD) by Region (2012-2022)
Figure The West Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2022)
Figure United States Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Carbetocin (Duratocin) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Carbetocin (Duratocin) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Carbetocin (Duratocin) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Carbetocin (Duratocin) Sales Share by Players/Suppliers
Figure 2017 United States Carbetocin (Duratocin) Sales Share by Players/Suppliers
Figure United States Carbetocin (Duratocin) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Carbetocin (Duratocin) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Carbetocin (Duratocin) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Carbetocin (Duratocin) Revenue Share by Players/Suppliers
Figure 2017 United States Carbetocin (Duratocin) Revenue Share by Players/Suppliers
Table United States Market Carbetocin (Duratocin) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Carbetocin (Duratocin) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Carbetocin (Duratocin) Market Share of Top 3 Players/Suppliers
Figure United States Carbetocin (Duratocin) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Carbetocin (Duratocin) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Carbetocin (Duratocin) Product Category
Table United States Carbetocin (Duratocin) Sales (K Units) by Region (2012-2017)
Table United States Carbetocin (Duratocin) Sales Share by Region (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Share by Region (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Market Share by Region in 2016
Table United States Carbetocin (Duratocin) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Carbetocin (Duratocin) Revenue Share by Region (2012-2017)
Figure United States Carbetocin (Duratocin) Revenue Market Share by Region (2012-2017)
Figure United States Carbetocin (Duratocin) Revenue Market Share by Region in 2016
Table United States Carbetocin (Duratocin) Price (USD/Unit) by Region (2012-2017)
Table United States Carbetocin (Duratocin) Sales (K Units) by Type (2012-2017)
Table United States Carbetocin (Duratocin) Sales Share by Type (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Share by Type (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Market Share by Type in 2016
Table United States Carbetocin (Duratocin) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Carbetocin (Duratocin) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Carbetocin (Duratocin) by Type (2012-2017)
Figure Revenue Market Share of Carbetocin (Duratocin) by Type in 2016
Table United States Carbetocin (Duratocin) Price (USD/Unit) by Types (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Growth Rate by Type (2012-2017)
Table United States Carbetocin (Duratocin) Sales (K Units) by Application (2012-2017)
Table United States Carbetocin (Duratocin) Sales Market Share by Application (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Market Share by Application (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Market Share by Application in 2016
Table United States Carbetocin (Duratocin) Sales Growth Rate by Application (2012-2017)
Figure United States Carbetocin (Duratocin) Sales Growth Rate by Application (2012-2017)
Table Beacon Pharmaceuticals Limited Basic Information List
Table Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Ferring Inc. Basic Information List
Table Ferring Inc. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Polypeptide Laboraries France Basic Information List
Table Polypeptide Laboraries France Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Chemos GmbH & Co. KG Basic Information List
Table Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Hangzhou Dayangchem Co. Ltd. Basic Information List
Table Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Acinopeptide Co., Ltd. Basic Information List
Table Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Bachem AG Basic Information List
Table Bachem AG Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Clearsynth Canada INC. Basic Information List
Table Clearsynth Canada INC. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Leap Labchem Co., Ltd Basic Information List
Table Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Chemieliva Pharmaceutical Co., Ltd. Basic Information List
Table Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales Growth Rate (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales Market Share in United States (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Revenue Market Share in United States (2012-2017)
Table Acinopeptide Co., Ltd. Basic Information List
Table BOC Sciences Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Carbetocin (Duratocin)
Figure Manufacturing Process Analysis of Carbetocin (Duratocin)
Figure Carbetocin (Duratocin) Industrial Chain Analysis
Table Raw Materials Sources of Carbetocin (Duratocin) Major Players/Suppliers in 2016
Table Major Buyers of Carbetocin (Duratocin)
Table Distributors/Traders List
Figure United States Carbetocin (Duratocin) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Carbetocin (Duratocin) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Type in 2022
Table United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Application in 2022
Table United States Carbetocin (Duratocin) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Carbetocin (Duratocin) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Carbetocin (Duratocin) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources